Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 533

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 533
---
 |     |              | 5,443,734 |     |              | 2,441,229 |     |               | —       |   |     |               | 4,691,734 |     |              | 2,441,229 |     |              | 1,723,967 |     |               | 1,555,967 |   |     |               |  0.46 |     |            | (23.0 | ) |
| 2023 |     |               |       — |     |              | 1,211,585 |     |              | 1,184,363 |     |               | —       |   |     |               | 1,211,585 |     |              |   559,019 |     |              |   325,030 |     |               |   369,631 |   |     |               |  3.82 |     |            | (15.0 | ) |
| 2022 |     |               | 682,827 |     |              |   800,083 |     |              | 3,161,028 |     |               | (37,000 | ) |     |               |   929,790 |     |              | 1,208,847 |     |              |   340,655 |     |               |  (125,878 | ) |     |               | 12.09 |     |            | (23.0 | ) |

| (1) | The dollar amounts reported in each column (a) are the amounts of total compensation reported for Dr. Bianco (TuHURA’s current Chief Executive Officers), (b) Robert Hoffman (TuHURA’s former Chief Executive Officer prior to the completion of the Kintara Merger) and (c) Mr. Saiid Zarrabian (TuHURA’s former Chief Executive Officer who served in such capacity during TuHURA’s former fiscal year ended June 30, 2022 until Mr. Hoffman’s appointment as TuHURA’s Chief Executive Officer, effective November 8, 2021) each as reported in TuHURA’s SCT for the applicable year. |

| (2) | The dollar amounts reported in these columns represent the amount of “compensation actually paid” to TuHURA’s PEOs and the average “compensation actually paid” to TuHURA’s non-PEO NEOs, as computed